Status in the House for the 91st Legislature (2019 - 2020)
Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
Authors added Loeffler and Dehn
Author added Persell
Author added Bierman